Le Lézard
Classified in: Health
Subjects: NPT, PER, DIS

MDA Taps Global Health Care Leader as CEO to Leverage New Breakthroughs and Amplify Mission


CHICAGO, Oct. 10, 2017 /PRNewswire-USNewswire/ -- After a nationwide search, the Muscular Dystrophy Association (MDA) today announced it has appointed Lynn O'Connor Vos as President and Chief Executive Officer. Vos previously was Global Chief Executive Officer of Greyhealth Group (ghg), a leading health care communications agency and part of the global WPP Group.

Lynn O'Connor Vos

"It truly feels as if my entire career path has been leading me to this role," said Vos. "I am excited to bring my passion for patient care and advocacy, as well as my success using new technology to build new, innovative communication approaches, to lead MDA in the fast-changing world of research and patient care."

With pediatric nursing as an early base, Vos has built successful health companies by applying trailblazing technology to new programs and efficiencies in patient care. She is the co-creator of Text4baby, the country's top mobile health program that has changed the health outcomes of mothers and infants. She has achieved additional success forging relationships and partnerships with institutions, providers and nonprofits to effect change and make a lasting impact in health care.

"We are grateful to have Lynn on board," said MDA Chairman of the Board R. Rodney Howell, M.D. "She is joining MDA at an incredibly important time for our organization, when the pipeline of promise in research is yielding more new drug approvals than ever before. I look forward to working with her as we continue to support MDA families through every stage of their journey with neuromuscular disease." 

Vos succeeds interim President and CEO Kristine Welker. A former Hearst Corporation executive, Welker has served in the interim role since February and will immediately resume her volunteer role as a member of MDA's Board of Directors.

"The inspiration stemming from new drug breakthroughs, together with the incredible impact of ongoing, community fundraising initiatives like the current 'Live Unlimited' campaign, inspire me to also seek to defy limits the way MDA families do," added Vos. "And I know the unprecedented leaders in corporate social responsibility that MDA has as its partners are right beside us as we continue to transform and save lives."

About Live Unlimited
The 2017 "Live Unlimited" campaign is an awareness and fundraising campaign featuring the "Live Unlimited" stories of three families impacted by a neuromuscular disease who challenged themselves to defy their own perceived limitations. The stories chronicle best friends who crossed the Camino de Santiago together, one woman's hike across the Pacific Coast Trail and a family from Los Angeles uniting to give their young son a chance to pursue his dreams. MDA is sharing these powerful stories with the American public to help raise awareness and to help more kids and adults living with muscular dystrophy, ALS and related life-threatening diseases feel empowered to pursue their personal and professional goals ? to live unlimited.

About Lynn O'Connor Vos ? MDA President and CEO
Vos will bring broad leadership capacity to MDA. She held her CEO position at ghg for nearly 23 years and is credited with creating, building and acquiring companies ? specifically, nine acquisitions ? to grow ghg's global footprint. While at ghg, Vos led global expansion and diversification strategies and within two years grew the company from a small, domestic professional player into an award-winning global enterprise with fully integrated, multi-channel offerings. She is a recognized thought leader in the industry with published white papers and articles outlining new, successful approaches to health care technology and communications. 

Honors and Positions

About the Muscular Dystrophy Association
MDA is leading the fight to free individuals ? and the families who love them ? from the harm of muscular dystrophy, ALS and related muscle-debilitating diseases that take away physical strength, independence and life. We use our collective strength to help kids and adults live longer and grow stronger by finding research breakthroughs across diseases; caring for individuals from day one; and empowering families with services and support in hometowns across America. Learn how you can fund cures, find care and champion the cause at mda.org.

 

Muscular Dystrophy Association logo. (PRNewsFoto/Muscular Dystrophy Association)

SOURCE Muscular Dystrophy Association


These press releases may also interest you

at 16:35
Bristol Myers Squibb today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progression-free survival (PFS) in unresectable, locally advanced stage III non-small cell lung cancer (NSCLC). CheckMate -73L evaluated...

at 16:35
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung...

at 16:35
Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution. Following that announcement, the Board of Directors declared a...

at 16:15
The Honourable Jean-Yves Duclos, MP for Québec and Minister of Public Services and Procurement, on behalf of the Honourable Mark Holland, Minister of Health, and  the Honourable Carla Qualtrough, Minister of Sport and Physical Activity, will announce...

at 16:15
Chemistree Technology Inc. and (the "Company" or "Chemistree"), announces that is has completed the previously announced restructuring transaction (the "Restructuring Transaction") to settle $6,668,000 in principal amount of outstanding 10% senior...

at 16:15
Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provided an...



News published on and distributed by: